Industry Reports
Bayer, BioNTech collaborate to develop mRNA vaccines & therapeutics for animal health applications
Bayer and BioNTech AG, a leading immunotherapy company headquartered in Mainz, Germany have entered into an agreement to develop novel, first-in-class mRNA vaccines and therapeutics specifically for Animal Health applications. BioNTech will contribute its proprietary mRNA...
Industry Reports
DePuy Synthes Companies of Johnson & Johnson acquired Biomedical Enterprises, inc
Acquisition of Nitinol Implant Company Strengthens Johnson & Johnson Medical Devices Position in Elective Extremity Surgery, the Fastest Growing Segment in Orthopaedics. DePuy Orthopaedics, Inc part of the DePuy Synthes Companies of Johnson & Johnson, announced...
Industry Reports
AstraZeneca acquired Takedas respiratory business
AstraZeneca announced that it has completed the acquisition of the core respiratory business of Takeda Pharmaceutical Company Limited . The agreement, announced in December 2015, includes the expansion of rights to roflumilast (marketed as Daliresp in the US and...
Industry Reports
The 2016 first quarter operating profit of Novo Nordisk increased by 10% in local currencies
Sales increased by 9% in local currencies and by 8% in Danish kroner to DKK 27.2 billion. Sales of Victoza® increased by 15% (16% in Danish kroner). Sales of Levemir® increased by 9% (8% in Danish kroner)....
Industry Reports
Abbott to acquire st. Jude medical
Combination will create a premier medical device leader and strengthen abbott's long-term growth potential Acquisition will enhance abbott's global scale and capabilities and will further diversify its portfolio of best-in-class products and revenue sources Combined portfolio will include...
Industry Reports
Aspen Technology reports Financial Results for the Third Quarter of Fiscal 2016
Aspen Technology, Inc ,a leading provider of software and services to the process industries, today announced financial results for its third quarter of fiscal year 2016, ended March 31, 2016. World pharma today/Industry reports/-Antonio Pietri, President...
Industry Reports
Bayer interim report for the first quarter shows a successful start of 2016
Bayer interim report for the first quarter shows a successful start of 2016Substantial sales growth at Pharmaceuticals / Earnings expand in all segments / Group sales increase to EUR 11,941 million (plus 0.5 percent / Fx & portfolio adj....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
